- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Influenza
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
High dose inactivated trivalent Influenza vaccine (split virion) – November 2019
High dose inactivated trivalent Influenza vaccine (split virion): Injection 0.5 mL; Fluzone® High-Dose
Last updated
9 July 2025